Reading a Term Sheet: Liquidation Prefs, Pro-Rata, Board

A term sheet is a short, mostly non-binding offer that sets the price and the power structure of your round — and three clauses decide most of what matters: the liquidation preference (who gets paid first and how much in an exit), pro-rata rights (which investors can keep buying to avoid dilution), and board composition (who actually controls the company). The headline valuation gets the attention, but these terms quietly determine how much you keep when you sell and who can overrule you before then. Read them in that order, because a high valuation attached to bad terms is worth less than a lower one with clean terms.

This is general information, not legal, tax, or financial advice. Term-sheet norms and securities rules change — have a startup lawyer review any sheet before you sign. Figures and market norms are described as of June 2026.

What is a term sheet, and what's actually binding?

A term sheet is a one-to-a-few-page summary of the proposed terms of an investment, and most of it is non-binding — it's an agreement to draft an agreement.

The clauses that usually do bind you are the no-shop/exclusivity (you can't shop the deal to other investors for a set window) and confidentiality. Everything else — valuation, preferences, board, rights — is a statement of intent that becomes legally enforceable only once it's translated into the definitive financing documents: the certificate of incorporation, stock purchase agreement, investor rights agreement, and voting agreement.

That distinction is why founders should slow down on terms and not just price.

The standard reference for what "market" looks like is the NVCA model legal documents, a free set of templates maintained by the National Venture Capital Association that most US venture deals are built on. When an investor's term sheet deviates from the NVCA defaults — a participating preference, a multiple over 1x, an investor-controlled board at seed — that deviation is the negotiation, and it's where a founder should spend their leverage.

How does a liquidation preference decide who gets paid first?

A liquidation preference is the rule for who gets paid, and how much, before anyone else when the company is sold or wound down — and it's the single clause most likely to surprise a founder at exit.

Preferred stock holders (your investors) get their preference off the top, ahead of common stock holders (you and your team). The two variables that matter are the multiple and whether it's participating.

The multiple is how many times their money they take first.

A 1x preference means an investor who put in $2M gets the first $2M out of any exit before common sees a dollar. A 2x or 3x preference doubles or triples that off-the-top claim — rare in healthy rounds, and a flag that the investor is pricing in risk or pushing hard terms. Per the NVCA model term sheet, 1x non-participating is the default, and it's what the large majority of US Series A rounds use.

Then there's the participating-versus-not question, which matters even more than the multiple.

Non-participating vs participating: the "double dip"

Non-participating preferred forces a choice: at exit, the investor takes either their preference OR converts to common and shares pro-rata — whichever pays more — but not both.

Participating preferred lets them do both: they take the preference off the top, then ALSO share in the remaining proceeds alongside common as if they'd converted. That's the "double dip," and in a modest exit it can swallow most of the founders' return. On a $10M sale with $4M of participating preferred, investors take $4M first, then a slice of the remaining $6M too — the rest is what's left for the cap table's common holders.

The smaller the exit, the more these terms decide your actual outcome.

If you negotiate one economic term on the sheet, make it this one. A 1x non-participating preference is the difference between sharing an exit fairly and watching investors get paid twice on the same dollars.

What are pro-rata rights, and why do investors fight for them?

Pro-rata rights give an existing investor the option — not the obligation — to invest in your future rounds enough to maintain their ownership percentage, instead of being diluted down as you raise more.

If a fund owns 10% after your seed and you raise a Series A, pro-rata lets them buy enough of the new round to stay at roughly 10%. Per the NVCA model documents, this is typically granted to "Major Investors" — those above a defined ownership or check-size threshold — and it's market-standard at Series A and beyond.

For founders, pro-rata is mostly benign, with two edges to watch.

The upside: it keeps your best early backers leaning in, and an investor who exercises pro-rata is signaling conviction. The risk is the "super pro-rata" variant, which lets an investor buy more than their existing percentage in the next round — that can crowd out the new lead you actually want and concentrate power early. Watch for super pro-rata or pro-rata combined with broad information and consent rights, and keep it to a select list of major investors rather than everyone on the cap table.

Pro-rata is about who gets to keep buying. Board composition is about who gets to decide.

Who actually controls the company after the round — the board?

Board composition decides company-level control — hiring and firing the CEO, approving budgets and future raises, and signing off on an acquisition — and it's the term founders most often under-weight relative to valuation.

A typical early structure is a small odd-numbered board. At seed it's often three seats: two founders and one investor, leaving founders in the majority. By Series A, the common move is a 2-1-2 — two founder/common seats, two investor seats, and one mutually agreed independent director — which means founders no longer have unilateral control.

The number of seats matters less than where the majority sits.

Separately from the board, term sheets carry protective provisions — a list of actions (selling the company, raising more, changing the charter, issuing senior stock) that require preferred-holder consent regardless of the board vote. These are normal, but read the list: an over-broad protective provision can hand an investor a veto over ordinary operating decisions, not just existential ones. The thing to optimize for at the early stage is keeping a founder-aligned board majority for as long as the company's risk profile justifies it.

What's the cross-border catch most term-sheet guides skip?

Here's the part the standard term-sheet explainer never mentions: almost every clause above assumes a Delaware C-Corp, because that's the entity the NVCA documents and US venture funds are built around — which makes your entity choice a fundraising decision, not just a tax one.

A US institutional lead will generally expect to buy preferred stock in a Delaware C-Corp. If you're an Indian or other non-US founder operating through an LLP, a Pvt Ltd, or a Wyoming LLC, raising priced venture money usually means flipping into a Delaware C-Corp first — and doing that after a term sheet lands is slow, expensive, and a bad time to discover it.

The differentiated move: if you know venture capital is the path, form the Delaware C-Corp the term sheet assumes before you start raising — so the day an investor sends the sheet, the entity, EIN, and US bank account already match what their lawyers expect.

This is exactly the gap StableCorp closes for non-resident founders.

StableCorp's default guidance is a Wyoming LLC for solo or bootstrapped founders and a Delaware C-Corp for the VC track — and it forms either one end to end, from incorporation through EIN to a US business bank account (which is rejected without an EIN). When your round closes and capital arrives, the same rails move it: StableCorp off-ramps USDC at 0.5% for incorporated clients, or 1% direct to INR, versus a cross-border wire's ~2.9% headline plus ~2% hidden FX — roughly 5% effective. See pricing for the full breakdown.

Get the structure right before the term sheet, not after it.

Term-sheet red flags to flag with your lawyer

Most term-sheet damage comes from a handful of recurring deviations from the NVCA defaults — these are the lines to circle before you sign.

None of these are automatically deal-killers, but each is a place where the standard market term is well-documented — so deviation should be a conscious trade, not something you missed.

The bottom line

Valuation gets the headline; liquidation preference, pro-rata, and board composition get the outcome.

Anchor your reading to the NVCA defaults, push hardest for a 1x non-participating preference and a founder-aligned board, and treat pro-rata and protective provisions as things to scope rather than rubber-stamp. And if VC is your path, set up the Delaware C-Corp the whole document set assumes before the sheet ever arrives.

Want the US entity, EIN, and bank account in place — and a compliant 0.5%-1% rail to move the money home — before your first term sheet lands? StableCorp handles the structure end to end; start at pricing, or read how to choose between an India topco and a US topco.

Sources